NCT01843387View on ClinicalTrials.gov

Safety and Efficacy of Mesenchymal Precursor Cells in Diabetic Nephropathy

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2015

Conditions
Diabetic NephropathyType 2 Diabetes
Interventions
BIOLOGICAL

Mesenchymal Precursor Cells (MPCs)

Single Intravenous Infusion of MPCs Dose 1 or Placebo

BIOLOGICAL

Mesenchymal Precursor Cells (MPCs)

Single Intravenous Infusion of MPCs Dose 2 or Placebo

Trial Locations (2)

Unknown

Monash Universtiy, Clayton

Melbourne Renal Research Group, Melbourne

Sponsors

Lead Sponsor

Mesoblast, Ltd.
All Listed Sponsors
lead

Mesoblast, Ltd.

INDUSTRY